| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 56.87B | 48.54B | 48.53B | 48.48B | 43.64B |
| Gross Profit | 16.46B | 13.63B | 12.74B | 11.94B | 10.87B |
| EBITDA | 4.72B | 4.13B | 3.74B | 3.35B | 2.77B |
| Net Income | 2.92B | 2.57B | 2.22B | 1.67B | 1.41B |
Balance Sheet | |||||
| Total Assets | 55.76B | 52.77B | 51.75B | 50.57B | 46.23B |
| Cash, Cash Equivalents and Short-Term Investments | 9.40B | 15.46B | 13.01B | 10.40B | 11.10B |
| Total Debt | 2.93B | 1.37B | 1.69B | 3.07B | 2.29B |
| Total Liabilities | 15.93B | 13.50B | 13.30B | 13.89B | 12.32B |
| Stockholders Equity | 39.83B | 39.28B | 38.46B | 36.68B | 33.91B |
Cash Flow | |||||
| Free Cash Flow | 2.14B | 4.10B | 3.91B | 333.63M | 1.86B |
| Operating Cash Flow | 2.99B | 4.62B | 4.40B | 850.63M | 2.64B |
| Investing Cash Flow | -5.02B | 638.66M | 77.81M | -135.11M | -401.71M |
| Financing Cash Flow | -4.14B | -2.68B | -1.98B | -1.92B | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.56B | 14.93 | ― | 4.16% | 10.09% | 54.33% | |
73 Outperform | ¥747.39B | 16.45 | 8.48% | 2.02% | ― | ― | |
72 Outperform | ¥41.83B | -29.01 | ― | 3.62% | -0.98% | -29.86% | |
72 Outperform | ¥70.87B | 3.05 | ― | 2.73% | 10.48% | -34.38% | |
71 Outperform | ¥288.74B | 19.60 | ― | 1.46% | 12.02% | -15.70% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
48 Neutral | ¥27.66B | 13.91 | ― | 4.99% | -7.21% | -5127.88% |